pembrolizumab
mirati,merck
['keytruda', 'pembro', '$mrtx']
$mrtx asco 2023 abstract: : acronyms 1,576 patients keytruda/ pembro obviously works well w/ pd-l1 (tps=&gt;50) majority (61%) of kras g12c samples have tps&lt;50 pd-l1 kras g12c cases have shortest survival... 
Self-professed investor in the ABC of tech: Autonomous EV (Tesla, I needed an excuse for A), Biotech and China tech

Display pic: NK Cell in Cells at Work anime